Medi Caps Ltd

₹ 25.0 -0.20%

23 Oct - close price

About

Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals^[1]

Key Points

Business Overview:^[1]
MCL operates in real estate as a parent company and pharma division through its wholly owned subsidiary. The company entered the real estate segment for city centric developments by way of Land acquisition and developing premium residential and commercial properties. It has almost completed its first project Medicaps Business Park and also sold ~50% of shops in the project

Website BSE NSE - BE

Market Cap ₹ 29.6 Cr.
Current Price ₹ 25.0
High / Low ₹ 44.7 / 20.3
Stock P/E
Book Value ₹ 53.5
Dividend Yield 0.00 %
ROCE -0.91 %
ROE -0.93 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 0.47 times its book value

Cons

Company has low interest coverage ratio.
Company has a low return on equity of 1.68% over last 3 years.
Company has high debtors of 466 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0.02	2.13	3.05	1.97	0.29	0.98	0.26	0.89	0.00	1.00	0.77	0.53	0.10
	0.37	0.16	0.87	0.93	0.69	0.59	0.57	0.68	0.67	0.68	0.59	0.87	0.64
Operating Profit	-0.35	1.97	2.18	1.04	-0.40	0.39	-0.31	0.21	-0.67	0.32	0.18	-0.34	-0.54
OPM %	-1,750.00%	92.49%	71.48%	52.79%	-137.93%	39.80%	-119.23%	23.60%		32.00%	23.38%	-64.15%	-540.00%
	0.01	0.00	0.00	0.14	0.11	0.10	0.09	0.27	0.31	0.01	0.17	0.08	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.07	0.05
Profit before tax	-0.38	1.93	2.14	1.14	-0.33	0.45	-0.26	0.44	-0.40	0.29	0.31	-0.33	-0.59
Tax %	0.00%	0.00%	21.03%	42.98%	0.00%	0.00%	0.00%	-61.36%	0.00%	0.00%	9.68%	-3.03%	0.00%
	-0.38	1.93	1.69	0.65	-0.33	0.45	-0.26	0.71	-0.40	0.29	0.29	-0.31	-0.59
EPS in Rs	-0.30	1.55	1.36	0.52	-0.26	0.36	-0.21	0.57	-0.32	0.23	0.23	-0.25	-0.47
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	27.37	25.04	22.76	26.38	25.28	10.91	0.00	0.00	0.10	7.17	2.42	2.31	2.40
	25.52	23.42	21.99	25.93	25.32	19.97	0.00	0.56	0.39	2.33	2.53	2.83	2.78
Operating Profit	1.85	1.62	0.77	0.45	-0.04	-9.06	0.00	-0.56	-0.29	4.84	-0.11	-0.52	-0.38
OPM %	6.76%	6.47%	3.38%	1.71%	-0.16%	-83.04%			-290.00%	67.50%	-4.55%	-22.51%	-15.83%
	1.21	0.46	1.13	0.67	1.14	1.11	-0.12	0.64	0.53	0.15	0.56	0.58	0.26
Interest	0.01	0.01	0.02	0.02	0.04	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Depreciation	0.32	0.33	0.37	0.34	0.35	0.36	0.00	0.09	0.09	0.16	0.16	0.19	0.20
Profit before tax	2.73	1.74	1.51	0.76	0.71	-8.32	-0.12	-0.02	0.15	4.83	0.29	-0.13	-0.32
Tax %	29.30%	32.18%	23.18%	26.32%	16.90%	0.12%	-8.33%	50.00%	0.00%	19.46%	-93.10%	15.38%
	1.94	1.18	1.16	0.56	0.59	-8.33	-0.11	-0.04	0.15	3.89	0.56	-0.14	-0.32
EPS in Rs	1.56	0.95	0.93	0.45	0.47	-6.68	-0.09	-0.03	0.12	3.12	0.45	-0.11	-0.26
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-21%
5 Years:	%
3 Years:	185%
TTM:	13%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	-10%
TTM:	-164%

Stock Price CAGR
10 Years:	0%
5 Years:	-9%
3 Years:	-15%
1 Year:	-37%

Return on Equity
10 Years:	-1%
5 Years:	1%
3 Years:	2%
Last Year:	-1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47	12.47
Reserves	51.89	53.07	53.90	54.45	55.04	47.38	48.50	48.82	48.64	54.02	54.87	54.24
	0.00	0.00	0.00	0.17	0.12	0.06	0.00	0.00	0.00	0.00	0.00	0.00
	4.58	5.47	5.64	4.73	6.16	1.65	1.66	0.52	0.52	1.60	0.68	0.63
Total Liabilities	68.94	71.01	72.01	71.82	73.79	61.56	62.63	61.81	61.63	68.09	68.02	67.34
	3.96	3.64	4.96	5.01	4.99	3.63	3.26	2.78	2.46	3.34	3.18	3.31
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.00
Investments	48.25	49.56	49.29	49.81	50.67	52.15	54.39	53.68	51.98	54.03	55.81	55.13
	16.73	17.81	17.76	17.00	18.13	5.78	4.98	5.35	7.19	10.72	8.95	8.90
Total Assets	68.94	71.01	72.01	71.82	73.79	61.56	62.63	61.81	61.63	68.09	68.02	67.34

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	6.88	1.44	2.70	0.86	1.33	-0.92	2.24	-0.95	-2.60	3.09	1.85	-0.47
	-6.78	-1.31	-1.76	-0.96	-1.19	-0.40	-2.19	1.01	1.85	-3.09	-1.85	0.42
	0.00	0.00	0.00	0.17	-0.05	-0.06	-0.06	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	0.10	0.13	0.94	0.07	0.09	-1.38	-0.02	0.06	-0.75	0.00	0.01	-0.05
Free Cash Flow	6.59	1.44	2.09	0.46	1.00	-0.92	2.28	-0.65	-2.45	3.13	1.78	-0.72
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	412%	122%	394%	231%	-3,575%	10%		170%	897%	83%	-1,445%	85%

Ratios

Standalone / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	88.55	96.35	97.18	96.02	90.24	88.99			8,176.00	236.72	552.02	466.13
Inventory Days	194.04	248.47	281.91	219.00	266.47	20.89	1,825.00
Days Payable	33.53	60.03	83.09	55.89	118.09	16.56	1,095.00
Cash Conversion Cycle	249.06	284.79	296.00	259.13	238.62	93.33			8,176.00	236.72	552.02	466.13
Working Capital Days	158.96	175.94	179.45	156.90	159.25	131.81			25,623.00	481.07	1,297.11	1,357.29
ROCE %	4.29%	2.69%	1.52%	1.14%	0.77%	-13.56%	0.00%	-0.85%	-0.62%	7.34%	-0.13%	-0.91%

Insights

In beta

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Number of Permanent Employees on Roll
Count

xxx	x	x	x	x	x	x	x
		xxx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xxx.xx	xx.xx						x.xx

Please log in to see hidden values.

Pharma Segment Revenue Share of Consolidated Revenue
%

Foreign Exchange Earnings from Exports
Rs. Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	50.13%	50.13%	50.13%	50.42%	50.61%	50.76%	50.76%	50.76%	50.76%	51.36%	51.44%	51.44%
	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%
	49.85%	49.84%	49.83%	49.54%	49.35%	49.21%	49.21%	49.19%	49.21%	48.61%	48.54%	48.53%
No. of Shareholders	13,226	12,356	11,738	11,255	11,176	11,033	10,851	10,692	10,493	10,349	10,209	10,369

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	50.14%	50.14%	50.14%	50.17%	50.14%	50.13%	50.13%	50.13%	50.76%	51.36%	51.44%
	0.27%	0.26%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%
	49.59%	49.60%	49.84%	49.80%	49.83%	49.84%	49.84%	49.84%	49.21%	48.61%	48.53%
No. of Shareholders	4,262	4,173	4,127	3,963	4,068	18,197	15,308	12,356	11,033	10,349	10,369

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Medi Caps Ltd

Medi Caps Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports